Clinical Trials Logo

Invasive Ductal Carcinoma clinical trials

View clinical trials related to Invasive Ductal Carcinoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01796041 Completed - Clinical trials for Invasive Ductal Carcinoma

Intraoperative Imaging of Breast Cancer With Indocyanine Green

ICG
Start date: July 2011
Phase: Early Phase 1
Study type: Interventional

According to the World Health Organization, breast cancer is the most common cancer in women, and is responsible for 686,000 new cases every year. The WHO also posit that nearly 420,000 women perished from the disease in 2002. Surgery remains the best option for patients presenting with operable Stage I, II or III cancers. Breast conservation surgery has been shown to be as efficacious as mastectomy. About 60-70% of these women with operable breast cancer are breast conservation candidates. However, the need to achieve negative tumor margins often requires a second operation (re-excision) in up to 70% of the women having lumpectomy surgery. Currently, tumor margins assessment in the operating room is often assessed grossly by palpation. The ability to evaluate tumor margin using our proposed intraoperative imaging technique may provide the surgeon with an alternative, and hopefully, more sensitive method to assess tumor margins which may decrease re-excision and the morbidity associated with additional surgery, and, perhaps, lower the risk of local regional recurrence.